Cart
sales@molnova.com
GLP-1R modulator C16
CAS No. 875005-43-9
GLP-1R modulator C16( —— )
Catalog No. M35241 CAS No. 875005-43-9
GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 138 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGLP-1R modulator C16
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4.
-
DescriptionGLP-1R modulator C16 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 8.43 ± 3.82 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number875005-43-9
-
Formula Weight408.89
-
Molecular FormulaC21H26ClFN2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (122.28 mM; Ultrasonic (<60°C)
-
SMILESCOc1cc(CNCCN2CCOCC2)ccc1OCc1c(F)cccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang J, et al. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site. ACS Chem Biol. 2021 Nov 19;16(11):2444-2452. ?
molnova catalog
related products
-
GLP-2(1-33)(human)
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium.
-
MK-0893
A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM).
-
Lotiglipron
Lotiglipron (PF-07081532) is an orally active, potent GLP-1R agonist that reduces blood glucose and body weight, potentially aiding in the study of type 2 diabetes mellitus (T2DM) and obesity.
